Lidocaine HCl Injection — Class II drug recall D-0636-2024
Ongoing recall by Fagron Compounding Services, reported 2024-08-28, distributed nationwide. Lack of Assurance of Sterility
| Recall number | D-0636-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Fagron Compounding Services, Wichita, KS, United States |
| Recall initiated | 2024-08-15 |
| Classified | 2024-08-16 |
| Reported by FDA | 2024-08-28 |
| Distributed | Nationwide (US) |
| Reason classes | sterility |
| Lot numbers | C274-000037397, C274-000037398, C274-000037399, C274-000037400 |
| Expiration dates | 2024-10-14 |
Product
Lidocaine HCl Injection, 2% (20mg per mL) (100 mg per 5 mL) per syringe, Rx only, Fagron Sterile Services, 8710 E. 34th St, N. Wichita, KS 57226.
Reason for recall
Lack of Assurance of Sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0636-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.